The cost of waiting: why health services should measure time to answer

NHS waiting targets count the time to a test or a treatment. What patients wait for is an answer. Measuring that would change how services are designed and judged.

26 October 2026 · 5 min read
7.4mReferral to treatment pathways waiting in England at the end of August 2026, around 6.2 million patients (NHS England)
24.7%Patients waiting six weeks or more for one of 15 key diagnostic tests, August 2026, against a 1% standard last met in 2013 (NHS England)
78.6%People told whether they had cancer within 28 days of an urgent referral, August 2026, against an 80% standard (NHS England)
£2.7bnMinimum extra pay for working-age patients by 2030/31 if elective waits returned to the 18-week standard (NHS England and ONS analysts, 2025)

At the end of August 2026, 7.4 million referral to treatment pathways were waiting in England, around 6.2 million patients. In 65.2% of cases the patient had waited up to 18 weeks, against a standard of 92%. The median wait was 12.2 weeks. More than 113,000 pathways had waited over a year.

Those numbers are familiar. They are reported every month and argued over every month. But they measure one particular thing: the time from referral to the start of treatment. For many patients that is not what they are waiting for. They are waiting to find out what is wrong, whether it is serious and what happens next. They are waiting for an answer.

What the targets count

The NHS has three main waiting measures, and each starts or stops its clock in a different place. The 18-week referral to treatment standard runs from referral to the first treatment. The diagnostic standard runs from referral to the test, not to the result. At the end of August 2026, 451,000 people, 24.7% of those waiting, had waited six weeks or more for one of 15 key tests. The standard is under 1%, and it was last met in November 2013.

Only one national measure counts the answer itself. The cancer Faster Diagnosis Standard asks whether a person referred urgently was told within 28 days that they have cancer, or that cancer has been ruled out. In August 2026, 78.6% were, against a standard of 80%. Crucially, a clear “no” counts. That is the right design. Most people referred urgently for suspected cancer do not have it, and for them the outcome that matters is being told so, quickly.

Share of patients seen within each waiting standard, England, August 2026%
Told cancer diagnosis or all-clear within 28 days (standard 80%)78.6%
Diagnostic test within 6 weeks (standard 99%)75.3%
Cancer treatment within 62 days (standard 85%)71.9%
Elective treatment within 18 weeks (standard 92%)65.2%

Source: NHS England, RTT, diagnostic and cancer waiting times statistics, October 2026 (diagnostic share calculated from the 24.7% waiting six weeks or more)

What waiting costs a patient

The cost of a slow answer is easiest to see in cancer. Cancer Research UK reports that around 90% of people diagnosed with stage 1 bowel cancer survive for five years or more. At stage 4, around 10% do. In 2022, 47% of bowel cancers in England with a known stage were caught at stage 1 or 2. Not every delay changes the stage. But the point of a fast diagnostic route is to catch more of the cases where it would.

Five-year survival for bowel cancer by stage at diagnosis, England, diagnosed 2016 to 2020%
Stage 190%
Stage 410%

Source: Cancer Research UK, Survival for bowel cancer, November 2024

For most conditions the cost is quieter. It is months of pain, worry and uncertainty. It is a job held on to with difficulty, or not held on to. The ONS found in 2023 that a third of economically inactive adults, excluding the retired, were waiting for NHS treatment. The 10 Year Health Plan, published in July 2025, noted that health-related economic inactivity had risen by 700,000 people since 2020.

What waiting costs the economy

In October 2025 analysts from NHS England and the ONS published preliminary findings that linked hospital records to tax data for around 30 million people. They estimated that bringing elective waits back to the 18-week standard would add at least £2.7 billion in extra pay for working-age patients by 2030/31, equivalent to 63,000 years of employment, with more than £1 billion back to the Exchequer.

That needs a counterweight. The Office for Budget Responsibility estimated in 2023 that 2.9 million working-age adults were on the waiting list in 2022, but that halving the list would reduce inactivity by only around 25,000. Shorter waits matter a great deal to the people waiting. They are not, on their own, a cure for the labour market.

Both findings point the same way. The value of a faster answer lies in the lives of the people who get it, and that value is real even where it does not show up in the national figures.

Demand is not slowing

The NHS met its interim target of 65% within 18 weeks in March 2026, at 65.3%. The Nuffield Trust noted that a short-term boost of over £100 million helped, and that progress stalled the following month. In the meantime demand keeps rising. The Nuffield Trust found weekly GP referrals up almost 20% in three years, from over 194,000 in June 2023 to over 227,000 in June 2026. The full 92% standard is due by March 2029.

When demand is rising and capacity is tight, how a service is designed matters as much as how hard it works. And design follows measurement. A service judged on time to treatment will optimise for treatment. A service judged on time to answer will look for ways to give people answers sooner, including the answer that they do not need treatment at all.

What this means: the measure a service reports shapes the service it becomes. If the patient is waiting for an answer, measure the answer.

How to measure time to answer

A service does not need a national standard to start. It needs four decisions.

First, start the clock at first contact. That means the day the patient first reached the service, whether by GP referral, self-referral or a call, not the day the referral was processed or the appointment booked.

Second, define the answer in the patient’s terms. A diagnosis, a clear all-clear, a plan the patient understands, or a discharge with advice. A test that has been done but not explained is not an answer.

Third, report the spread, not just the share inside a target. NHS England publishes the median and the 92nd percentile for referral to treatment. A service should do the same, because the patients at the long end are where the harm sits.

Fourth, split it by who is waiting. Deprivation, age and digital access all change how long people wait and how easily they get through. A median that improves overall can hide a group that is falling behind.

Most services hold the data for this already, in referral systems, booking systems and clinical letters. Joining it up is a modest piece of work. The harder part is deciding to report it.

The test we apply to our own work is whether anyone’s life changed, and whether we can show it. For someone waiting, the change starts the day they are told what is wrong, or that nothing is. A service that can show it is getting that answer to people sooner, and to the people who used to wait longest, is changing lives in a way any patient would recognise.

Newsletter

Practical ideas, once a month.

Website, growth and marketing tips for small and growing businesses. No spam, and you can unsubscribe at any time.